Affordable Care Act

Former HealthCare.gov comms staffers fill in for the government with ACA campaign

Former HealthCare.gov comms staffers fill in for the government with ACA campaign

By

Get America Covered is working to encourage consumers to sign up for coverage through the Affordable Care Act.

Five things for pharma marketers to know: Wednesday, October 4, 2017

Five things for pharma marketers to know: Wednesday, October 4, 2017

By

The FDA approves Mylan's Copaxone generic; 3 out of every 1,000 Americans face $50,000 in drug costs; some ACA premiums may rise by 50%

Oscar Health launches open enrollment campaign, as funding is slashed for ACA ads

Oscar Health launches open enrollment campaign, as funding is slashed for ACA ads

By

The health insurance startup launched a campaign this week that urges people to get covered.

Five things for pharma marketers to know: Friday, August 25, 2017

Five things for pharma marketers to know: Friday, August 25, 2017

By

Google surveys for depression; patients with diabetes that adhere to their regimen had fewer ER visits; Biogen, Samsung scores Humira biosimilar approval in EU

Five things for pharma marketers to know: Friday, May 19, 2017

Five things for pharma marketers to know: Friday, May 19, 2017

By

Keytruda gets two new FDA approvals; lawmakers aim to speed up approval of generics; Incyte uses soap opera to spread rare-disease awareness

Humana navigates health insurance ups and downs

Humana navigates health insurance ups and downs

By

Tom Noland says protecting and enhancing Humana's reputation comes down to three things: corporate volunteerism, good media relations, and content creation.

Five things for pharma marketers to know: Monday, March 20, 2017

Five things for pharma marketers to know: Monday, March 20, 2017

By

Study finds SGLT-2 inhibitors lowered risk of death; former FDA commissioners raise drug importation issues; Bayer, J&J's Xarelto lowered VTE risk in study

New healthcare bill to negatively affect drugmakers: Moody's

New healthcare bill to negatively affect drugmakers: Moody's

By

Per the credit ratings agency, more uninsured Americans will lead to less demand for healthcare services and treatments.

Five things for pharma marketers to know: Tuesday, March 7, 2017

Five things for pharma marketers to know: Tuesday, March 7, 2017

By

GOP unveils ACA replacement; Trump is working on new drug-pricing system; researchers to study thousands of immunotherapies

Five things for pharma marketers to know: Monday, February 27, 2017

Five things for pharma marketers to know: Monday, February 27, 2017

By

Pfizer receives subpoena over patient assistance programs; drugmakers raise prices less this January than last; lawmakers have new plan to repeal ACA

Five things for pharma marketers to know: Wednesday, January 25, 2017

Five things for pharma marketers to know: Wednesday, January 25, 2017

By

Novartis forecasts slower growth in 2017; Actelion reports trial failure for PAH drug; HHS nominee Tom Price denies conflict of interest claims

Healthcare communicators track Obamacare repeal debate

Healthcare communicators track Obamacare repeal debate

By

Many healthcare comms leaders are paying close attention to the debate between "access" to healthcare versus making it a requirement, experts say.

Trump administration raises questions for rare-disease drugmakers

Trump administration raises questions for rare-disease drugmakers

By

Nobody knows what the future holds for the Affordable Care Act under the Trump administration and an emboldened Republican Congress.

Five things for pharma marketers to know: Thursday, January 12, 2017

Five things for pharma marketers to know: Thursday, January 12, 2017

By

Trump says pharma is "getting away with murder"; Senate majority votes to repeal ACA; IBM Watson Health and FDA to study blockchain technology

Five things for pharma marketers to know: Tuesday, November 29, 2016

Five things for pharma marketers to know: Tuesday, November 29, 2016

By

Trump selects Price as head of HHS; Warren criticizes 21st Century Cures; GSK CEO says companies will have to get used to making less money

10 Things for Trump to Consider When It Comes to Healthcare

10 Things for Trump to Consider When It Comes to Healthcare

Peter Pitts calls for Trump to eliminate the Independent Payment Advisory Board and direct the FDA to issue guidance on off-label communications.

Five things for pharma marketers to know: Thursday, November 17, 2016

Five things for pharma marketers to know: Thursday, November 17, 2016

By

Former Valeant and Philidor execs arrested; at least 1 million enroll in 2017 exchange plans; mobile game helps scientists study dementia

Five things for pharma marketers to know: Friday, November 11, 2016

Five things for pharma marketers to know: Friday, November 11, 2016

By

Trump says he will reform the FDA; pharmaceutical M&A expected to pick up; superbug causing infections in cystic-fibrosis patients

How Ascension's Nick Ragone is rebranding one of the biggest U.S. health systems

How Ascension's Nick Ragone is rebranding one of the biggest U.S. health systems

By

The health system is one of the largest in the country. Most of Ascension's hospitals, Ragone says, used to operate almost independently from each other and the company's headquarters.

Five things for pharma marketers to know: Monday, November 7, 2016

Five things for pharma marketers to know: Monday, November 7, 2016

By

Bayer submits Stivarga to FDA for liver-cancer indication; emails show FDA's divisiveness over Duchenne drug approval; insurers want new president to address ACA financial risks

Trump or Clinton? Either May Lead to Better Mental Healthcare

Trump or Clinton? Either May Lead to Better Mental Healthcare

Despite political rifts that have blocked progress on so many other fronts, Congress has managed to lay the groundwork for clear steps forward in mental health.

Health exchanges, Obama administration challenged by recent insurer exits

Health exchanges, Obama administration challenged by recent insurer exits

By

The pull-back of insurance providers has left state-run health exchanges and the Obama administration facing a difficult communications challenge.

Clinton or Trump? Either Way, Change Is Coming

Clinton or Trump? Either Way, Change Is Coming

Donald Trump and Hillary Clinton offer clear contrasts on the issues of the Affordable Care Act, entitlement reform, and drug pricing.

Five things for pharma marketers to know: Wednesday, March 2, 2016

Five things for pharma marketers to know: Wednesday, March 2, 2016

By

The doc shortage may be due, in part, to changing marriage patterns; Olympus settles anti-kickback case; U.K. says Imbruvica is too expensive

3 Ways Insurers Can Integrate Digital Strategies into the Marketing Mix

3 Ways Insurers Can Integrate Digital Strategies into the Marketing Mix

As more healthcare patients move online, it is imperative that marketers use the right marketing strategy to keep them engaged—a strategy that should always include digital advertising.

Q&A: Why McCann Health set up a pharmacy focused agency

Q&A: Why McCann Health set up a pharmacy focused agency

By

A Q&A with Sandra Carey, president of the McCann Pharmacy Initiative, on the move to push pharmacy to the forefront.

Market Access: Looking Back, Looking Ahead

Market Access: Looking Back, Looking Ahead

Securing market access has become significantly more challenging for pharma marketers.

What if Hospital Meant Hospitality?

What if Hospital Meant Hospitality?

How to bring an enhanced customer experience to the healthcare industry

Physicians Interactive acquires Quantia

Physicians Interactive acquires Quantia

By

The deal is expected to complement the company's digital health platform.

Study: 10 medications will cost US $50 billion over 10 years

Study: 10 medications will cost US $50 billion over 10 years

By

An analysis by Avalere Health says 10 breakthrough therapy drugs will account for billions in spending.